News

Survival rates for Black women are far worse after bystander CPR than for white men, according to a study published this month.

USA Today talked to Dr. Paul Chan about disparities found when analyzing the effectiveness of bystander CPR for cardiac arrest.

Dr. Tim Pluard talks about an exciting expansion that will make cancer care more accessible to Kansas City’s growing Northland community.

The new ultrasound probe, which will primarily be used in the hospital's emergency department, provides a detailed view of what's happening in a patient's body in real-time.

Cardiovascular Business spoke with Dr. Timothy Bateman about his views on SPECT advances and its longevity in the coming years.

Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.

We’re talking about how younger women and men can monitor for breast cancer and recent updates in screening guidelines.

Dr. Timothy Bateman spoke with Cardiovascular Business about his group's findings and what it is like to work with flurpiridaz.